It may be hard to remember now, but when 2020 began, there was speculation that there could be major drug pricing legislation in a post-Election Lame Duck session.
There was some logic to the idea back in January and February. At that point, it was pretty clear that the Republicans and Democrats were dug in on campaign positioning...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?